只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-25 2026-06-26 | KRYS Krystal Biotech, Inc. | Thomas John Charles Officer · EVP, General Counsel | 卖出（S） | 1,000 | US$347.27 | US$347,270.00 | 0 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 320 | US$300.75 | US$96,240.00 | 1,474,933 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 640 | US$302.24 | US$193,433.60 | 1,474,293 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 176 | US$303.17 | US$53,357.92 | 1,474,117 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 40 | US$312.23 | US$12,489.20 | 1,450,253 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 964 | US$311.36 | US$300,151.04 | 1,450,293 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 2,652 | US$310.43 | US$823,260.36 | 1,451,257 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 2,784 | US$309.49 | US$861,620.16 | 1,453,909 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 4,830 | US$308.47 | US$148.99万 | 1,456,693 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 544 | US$304.81 | US$165,816.64 | 1,473,573 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 589 | US$306.33 | US$180,428.37 | 1,472,984 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Krish S Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 11,461 | US$307.68 | US$352.63万 | 1,461,523 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 320 | US$300.75 | US$96,240.00 | 1,402,835 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 593 | US$302.25 | US$179,234.25 | 1,402,242 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 247 | US$303.17 | US$74,882.99 | 1,401,995 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 400 | US$304.89 | US$121,956.00 | 1,401,595 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 480 | US$305.87 | US$146,817.60 | 1,401,115 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 240 | US$311.65 | US$74,796.00 | 1,378,155 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 12,729 | US$307.81 | US$391.81万 | 1,387,038 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 3,803 | US$308.89 | US$117.47万 | 1,383,235 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 2,801 | US$309.95 | US$868,169.95 | 1,380,434 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 2,039 | US$310.94 | US$634,006.66 | 1,378,395 | SEC |
| 2026-06-04 2026-06-05 | KRYS Krystal Biotech, Inc. | Krishnan Suma Director,Officer,TenPercentOwner · President, R&D | 卖出（S） | 1,348 | US$307.09 | US$413,957.32 | 1,399,767 | SEC |
| 2026-05-26 2026-05-27 | KRYS Krystal Biotech, Inc. | Thomas John Charles Officer · EVP, General Counsel | 卖出（S） | 642 | US$302.03 | US$193,903.26 | 0 | SEC |
| 2026-05-07 2026-05-08 | BWIN Baldwin Insurance Group, Inc. | Krystyn Elizabeth Other | 卖出（S） | 98,278 | US$21.20 | US$208.35万 | 0 | SEC |
| 2026-05-07 2026-05-08 | BWIN Baldwin Insurance Group, Inc. | Krystyn Elizabeth Other | 卖出（S） | 31,740 | US$21.18 | US$672,253.20 | 0 | SEC |
| 2026-05-06 2026-05-08 | BWIN Baldwin Insurance Group, Inc. | Krystyn Elizabeth Other | 卖出（S） | 53,722 | US$21.19 | US$113.84万 | 98,278 | SEC |
| 2026-05-06 2026-05-08 | BWIN Baldwin Insurance Group, Inc. | Krystyn Elizabeth Other | 卖出（S） | 18,260 | US$21.20 | US$387,112.00 | 31,740 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| KRYS | 129,232.6197 | 30 | 181,788.342 | 71.09% | B, Q, N |